ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Determination of Gene-Level Fitness Contributions Across the Mucin-Utilization Network of Bacteroides thetaiotaomicron.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Host mucus is a major nutrient reservoir for gut Bacteroidota, yet the gene-level determinants of mucin utilization remain poorly defined. In this study, we used a genome-scale CRISPR interference library in Bacteroides thetaiotaomicron to systematically map fitness contributions across the mucin-utilization network, spanning surface accessibility, glycan degradation, and intracellular sugar assimilation. Our screen identified 1,256 genes with condition-dependent fitness divergence, which revealed a layered organization of mucin-dependent growth. A prominent mucin-specific fitness signature was enrichment of strains with repressed capsular polysaccharide loci. Subsequent competition and deletion experiments validated that specific capsules impede growth on mucin, supporting a surface-accessibility trade-off model. By contrast, most mucin-induced carbohydrate-binding and glycoside hydrolase genes showed negligible fitness contributions, consistent with functional redundancy in extracellular glycan capture and processing. Conversely, downstream sugar catabolism showed pronounced condition-specific constraints, with the galactose-utilization gene BT_0623, causing measurable fitness defects upon repression in both mucin- and galactose-containing media. Finally, comparison with murine colon CRISPRi data revealed broad concordance with the in vitro mucin fitness landscape, while also highlighting environment-specific differences, in CPS- and polysaccharide degradation-associated functions. Together, these results define mucin utilization as a layered fitness architecture governed by surface-accessibility costs, redundant extracellular glycan processing, and downstream metabolic constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.